We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALBPS market cap is 2.53M. The company's latest EPS is EUR -0.0249 and P/E is -119.28.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.86M | -15.68M | -13.94M | -26.82M | -23.27M |
| Net Income | -13.99M | -17.79M | -25.52M | -31.16M | -24.22M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 21.86M | 17.67M | 27.21M | 34.87M | 21.99M |
| Total Liabilities | 14.86M | 25.2M | 24.94M | 29.07M | 23.9M |
| Total Equity | 7.01M | -7.53M | 2.27M | 5.8M | -1.91M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -12.34M | -15.27M | -9.74M | -23.8M | -18.99M |
| Investing | -104k | -278k | -12.71M | 12.16M | -17k |
| Financing | 7.06M | 7.5M | 21.95M | 29.72M | 6.13M |
| Market Cap | 2.53M |
| Price to Earnings Ratio | -119.28 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 260.53 |
| Price to Book Ratio | -1.51k |
| Dividend Yield | - |
| Shares Outstanding | 973.52M |
| Average Volume (1 week) | 133.42M |
| Average Volume (1 Month) | 55.5M |
| 52 Week Change | -93.25% |
| 52 Week High | 0.0396 |
| 52 Week Low | 0.0024 |
| Spread (Intraday) | 0 (3.85%) |
| Company Name | Biophytis |
| Address |
14 avenue de l’opera paris, paris 75001 |
| Website | https://www.biophytis.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
